Clinical Trial Update: Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating biweekly TPF induction chemotherapy for locally advanced head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Carcinoma

Drugs mentioned

• TPF induction chemotherapy (biweekly regimen)

Snippet

Sponsor: China Medical University Hospital | Conditions: Locally Advanced Head and Neck Carcinoma | Phase 2 | Status: COMPLETED